Greifswalder microbiome analysis gastrointestinal cancer
- Conditions
- C16.9C15.9Stomach, unspecifiedOesophagus, unspecified
- Registration Number
- DRKS00033357
- Lead Sponsor
- niversitätsmedizin Greifswald, Klinik für Allgemeine Chirurgie, Viszeral-, Thorax- und Gefäßchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
•histologically confirmed carcinoma, or high suspicion of a carcinoma based on imaging
•the patient must be capable of understanding the content of the consent form and provide written consent to participate
Exclusion Criteria
•pregnancy/nursing women
•patients unable to give consent
•second neoplasia = 5 years before study enrollment
•chronic inflammatory bowel disease under treatment
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Examination of the gastrointestinal microbiome and therapy-associated changes
- Secondary Outcome Measures
Name Time Method Correlation of the microbiome with clinical parameters and quality of life